Regulation of lung cancer cell growth and invasiveness by beta-TRCP

Nonggao He1, Chengxin Li, Xiaoli Zhang

  • 1Sealy Center for Cancer Cell Biology and Environmental Medicine, University of Texas Medical Branch at Galveston, Texas 77555, USA.

Molecular Carcinogenesis
|November 13, 2004
PubMed

Insights

Beta-transducin-repeat-containing protein (beta-TRCP) loss promotes lung cancer growth and motility. Restoring beta-TRCP1 inhibits tumor formation and invasion, potentially via CDC25A and MMP11 regulation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Beta-transducin-repeat-containing protein (beta-TRCP) is a key component of SCF(beta-TRCP) E3 ubiquitin ligases, regulating critical signaling pathways and cell mitosis.
  • SCF(beta-TRCP) E3 ligases are implicated in various cellular processes, including cell division and signaling.

Purpose of the Study:

  • To investigate the role of beta-TRCP in lung cancer progression.
  • To determine if beta-TRCP negatively regulates lung cancer cell growth and motility.

Main Methods:

  • Analysis of beta-TRCP1 protein and gene status in lung cancer cell lines and specimens.
  • Retrovirus-mediated expression of beta-TRCP1 in beta-TRCP1-deficient cells.
  • Assessment of cell growth (soft-agar assay) and tumor formation in nude mice.
  • Evaluation of cell motility, matrix metalloproteinase (MMP)11 activity, and cell invasion.
  • Investigation of cell division cycle 25 (CDC25)A levels and effects of CDC25A inhibitors.

Main Results:

  • Loss of beta-TRCP1 protein was observed in several lung cancer cell lines and subsets of lung cancer specimens.
  • Stable expression of beta-TRCP1 inhibited cell growth in soft-agar and reduced tumor formation in vivo.
  • Beta-TRCP1 expression altered cell motility, decreased active MMP11 levels, and reduced invasion.
  • Inactivation of beta-TRCP1 using siRNA accelerated cell invasion.
  • The protein level of CDC25A was affected in lung cancer cells lacking beta-TRCP1.
  • CDC25A inhibition reduced cancer cell invasiveness.

Conclusions:

  • Loss of beta-TRCP1 expression promotes lung cancer cell growth and motility.
  • Beta-TRCP1 may exert its tumor-suppressive function through the regulation of CDC25A and MMP11.
  • Restoring beta-TRCP1 function could be a potential therapeutic strategy for lung cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...